Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 24
Phase 31
Phase 45

Trial Status

Completed12
Recruiting2
Other1

Role Distribution

Principal Investigator15
PI Rate100%

Activity Timeline

Clinical Trials (15)

NCT06261021Phase 2Recruiting
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus
Discoid Lupus Erythematosus
PrincipalinvestigatorStart date: 2024-04-19
NCT05994976Recruiting
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
AcneAtopic DermatitisChronic Hand Eczema+3 more
PrincipalinvestigatorStart date: 2023-10-17
NCT05835843Completed
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
Plaque Psoriasis
PrincipalinvestigatorStart date: 2023-06-02
NCT05844618Phase 4Completed
Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis
Atopic Dermatitis
PrincipalinvestigatorStart date: 2023-05-09
NCT04537468Not ApplicableCompleted
Development of a Method to Measure mRNA Levels in Skin Samples
Atopic Dermatitis EczemaHealthyPsoriasis
PrincipalinvestigatorStart date: 2017-05-11
NCT00640393Phase 4Completed
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
Psoriasis Vulgaris
Principalinvestigator
NCT00837551Phase 1/2Completed
Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
Dermatitis, Atopic
Principalinvestigator

Showing 10 of 15 trials

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (15)

Showing 15 of 15 trials

NCT06283550Phase 2PrincipalInvestigator

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

Chronic Hand Eczema
Completed
NCT06261021Phase 2PrincipalInvestigator

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Discoid Lupus Erythematosus
Recruiting
NCT05994976PrincipalInvestigator

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

AcneAtopic DermatitisChronic Hand Eczema+3 more
Recruiting
NCT05835843PrincipalInvestigator

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

Plaque Psoriasis
Completed
NCT05844618Phase 4PrincipalInvestigator

Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis

Atopic Dermatitis
Completed
NCT05602207Phase 4PrincipalInvestigator

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Atopic Dermatitis
Completed
NCT04537468Not ApplicablePrincipalInvestigator

Development of a Method to Measure mRNA Levels in Skin Samples

Atopic Dermatitis EczemaHealthyPsoriasis
Completed
NCT00640393Phase 4PrincipalInvestigator

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

Psoriasis Vulgaris
Completed
NCT00837551Phase 1/2PrincipalInvestigator

Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis

Dermatitis, Atopic
Completed
NCT00927069Phase 3PrincipalInvestigator

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

Plaque Psoriasis
Completed
NCT00967538Phase 4PrincipalInvestigator

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Psoriasis
Completed
NCT01139918PrincipalInvestigator

Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis

PsoriasisPsoriatic Arthritis
Completed
NCT01490736Phase 1/2PrincipalInvestigator

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

Acne
Completed
NCT01978483Phase 1PrincipalInvestigator

Effect of RANKL Inhibition on UV-induced Immunosuppression

Hypersensitivity, DelayedImmune Tolerance/Drug EffectsImmunosuppression+1 more
Completed
NCT05499416Phase 4PrincipalInvestigator

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Active Psoriatic ArthritisPsoriasis Vulgaris
Withdrawn

All 15 trials loaded